Metabolic Cost of Battle Rope Training (BRT-UTH)

February 27, 2023 updated by: Ioannis G. Fatouros, University of Thessaly
In this study, the investigators will be able to estimate the metabolic cost of several foundational battle rope training exercises.

Study Overview

Detailed Description

Battle rope training has become a popular cardiovascular training choice in fitness centers and athletic performance enhancement facilities. Despite widespread use and growing popularity, little is known about the metabolic demands of such a training method. Therefore, the purpose of this study was to quantify the cardiovascular and metabolic cost from various foundational battle rope exercises in order to contribute to a better planning of exercise programs in the real world.

Ten healthy young adults were assigned to execute seven bodyweight exercises (acute bout) for 30 and 45 seconds. Anthropometric, metabolic, functional capacity and performance measurements were conducted at baseline. The metabolic cost was estimated from heart rate, blood lactate, resting oxygen uptake, exercise oxygen uptake, and excess post-exercise oxygen consumption measurements using a portable gas analyzer.

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Trikala, Greece, 42100
        • Laboratory of Exercise Physiology, Exercise Biochemistry and Sports Nutrition, School of Physical Education, Sports Sciences and Dietetics, University of Thessaly

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Aged between 18 and 35 years
  • Physically active individuals
  • Free of chronic diseases
  • Free of musculoskeletal injuries
  • Nonsmokers

Exclusion Criteria:

  • Musculoskeletal injuries
  • Chronic diseases
  • Use of alcohol, caffeine and any type of ergogenic supplements or medication before (≤6 months) and throughout the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
Participants in this arm will receive no intervention.
Experimental: Training
Participants in this arm will perform five battle rope training exercises (acute bout per exercise) at two different conditions (30 and 45 seconds).
Battle rope training exercises will be performed for 30 seconds and the training volume will be consisted of 1 repetition.
Battle rope training exercises will be performed for 45 seconds and the training volume will be consisted of 1 repetition.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in exercise-induced energy expenditure
Time Frame: At pre-exercise, during and 30 minutes after exercise session (single bout lasting 30 and 45 seconds)
Exercise energy expenditure (kcal) will be measured using a portable indirect calorimetry system
At pre-exercise, during and 30 minutes after exercise session (single bout lasting 30 and 45 seconds)
Change in excess post-exercise oxygen consumption (EPOC)
Time Frame: At 1 hour after exercise session (single bout lasting 30 and 45 seconds)
EPOC (kcal) will be measured using a portable indirect calorimetry system
At 1 hour after exercise session (single bout lasting 30 and 45 seconds)
Change in blood lactate concentration (BLa)
Time Frame: At pre exercise and at 3 minutes after exercise session
BLa (mmol/L) concentration will be measured in a microphotometer with commercially available kits.
At pre exercise and at 3 minutes after exercise session
Change in heart rate
Time Frame: At pre-exercise, during, and 30 minutes after exercise session (single bout lasting 30 and 45 seconds
Heart rate (bpm) will be measured with a wearable heart rate monitor
At pre-exercise, during, and 30 minutes after exercise session (single bout lasting 30 and 45 seconds
Change in perceived exertion
Time Frame: At pre-exercise, during, and 30 minutes after exercise session (single bout lasting 30 and 45 seconds
Rating of perceived exertion (RPE) will be measured with the Borg scale (0-10)
At pre-exercise, during, and 30 minutes after exercise session (single bout lasting 30 and 45 seconds

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body weight
Time Frame: At baseline
Body weight will be measured on a beam balance with stadiometer
At baseline
Body height
Time Frame: At baseline
Body height will be measured on a beam balance with stadiometer
At baseline
Body mass index (BMI)
Time Frame: At baseline
BMI will be calculated using the Quetelet's equation
At baseline
Waist circumference (WC)
Time Frame: At baseline
WC (cm) will be measured using a Gullick II tape
At baseline
Hip circumference (HC)
Time Frame: At baseline
HC (cm) will be measured using a Gullick II tape
At baseline
Waist-to-hip ratio (WHR)
Time Frame: At baseline
WHR will be calculated by dividing the waist by the hip measurement
At baseline
Resting metabolic rate (RMR)
Time Frame: At baseline
RMR (kcal) will be measured using a portable open-circuit indirect calorimeter with a ventilated hood system
At baseline
Fat-free mass (FFM)
Time Frame: At baseline
FFM (kg) will be assessed by whole-body dual-energy X-ray absorptiometry (DXA)
At baseline
Maximal oxygen consumption (VO2max)
Time Frame: At baseline
VO2max (mL/kg/min) will be assessed by a portable open-circuit spirometry system
At baseline
Muscular endurance
Time Frame: At baseline
Muscular endurance (repetitions) will be measured on a 1-min curl-up and push-up test.
At baseline
Body fat (BF) Body fat (%) will be assessed by whole-body dual-energy X-ray absorptiometry (DXA)
Time Frame: At baseline
BF (%) will be assessed by whole-body dual-energy X-ray absorptiometry (DXA)
At baseline
Fat mass (FM)t Body fat (%) will be assessed by whole-body dual-energy X-ray absorptiometry (DXA)
Time Frame: At baseline
FM (kg) will be assessed by whole-body dual-energy X-ray absorptiometry (DXA)
At baseline
Maximal strength (1RM)
Time Frame: At baseline
1RM (kg) will be measured bilaterally on a horizontal leg press and seated chest press machine.
At baseline
Functional capacity
Time Frame: At baseline
Functional capacity will be assessed using a movement-based screening tool titled Functional Movement Screening (FMS). The FMS will be consisted of 7 movement tasks that will be scored from 0 to 3 points and the sum will create score ranging from 0 to 21 points (0 = pain with pattern regardless of quality, 1 = unable to perform pattern, 2 = able to perform pattern with compensation/imperfection, 3 = able to perform pattern as directed)
At baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2022

Primary Completion (Actual)

December 30, 2022

Study Completion (Actual)

December 31, 2022

Study Registration Dates

First Submitted

June 1, 2022

First Submitted That Met QC Criteria

June 7, 2022

First Posted (Actual)

June 9, 2022

Study Record Updates

Last Update Posted (Estimate)

February 28, 2023

Last Update Submitted That Met QC Criteria

February 27, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Body Composition

Clinical Trials on BR-30

Subscribe